Showing results (91-100 of 220) with videos related to
Sort By:
Pageof 22
The American Journal of Gastroenterology|March 1, 1995
Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitisB A Lashner, K S Provencher, J M Bozdech, et al.Cleveland Clinic Journal of Medicine|September 1, 1995
Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel diseaseA Brzezinski, G B Rankin, D L Seidner, et al.The American Journal of Gastroenterology|January 11, 2001
Infliximab in Crohn's disease: first anniversary clinical experienceR D Cohen, J F Tsang, S B HanauerGut|May 1, 1995
Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's diseaseG R D'Haens, A E Gasparaitis, S B HanauerAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1992
Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranesC A DeSoi, D F Sahm, J G UmansThe American Journal of Gastroenterology|February 18, 1999
Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitisB A Lashner, B D Shapiro, A Husain, et al.The American Journal of Gastroenterology|October 15, 1998
Sarcoidosis presenting as granulomatous colitisJ A Dumot, K Adal, R E Petras, et al.Emerging Infectious Diseases|June 11, 1998
Multiple-drug resistant enterococci: the nature of the problem and an agenda for the futureM M Huycke, D F Sahm, M S GilmoreAntimicrobial Agents and Chemotherapy|April 1, 1992
Effects of amino acids on expression of enterococcal vancomycin resistanceL J Zarlenga, M S Gilmore, D F SahmThe Journal of Antimicrobial Chemotherapy|August 26, 2016
Comparative in vitro activities of ceftaroline and ceftriaxone against bacterial pathogens associated with respiratory tract infections: results from the AWARE surveillance studyD J Biedenbach, J P Iaconis, D F SahmPageof 22